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Introduction: Techniques using PSMA radioligands have emerged as diagnostic and therapeutic alternatives in prostate 
cancer. Significant adverse events resulting from using beta-emitters such as 177Lu-PSMA for castration-resistant 
prostate cancer therapy include sialotoxicity and xerostomia. Sialotoxicity ranges from 8% mild to moderate up to 10% 
interruption of treatment, depending on the compound used, due to the physiological expression of PSMA in the salivary 
glands and consequent radioligand uptake. Cooling with icepacks emerged as a possible intervention to prevent this event. 
The rationale is that cold- induced vasoconstriction would lead to a reduction of the perfusion of the gland, similarly to 
scalp cooling applied in some chemotherapies. Although empirically used in European protocols, the efficacy of this 
technique was assessed in only one study, with no evidence of success. The objective of this work was to analyze the 
efficacy of salivary gland cooling in the reduction of PSMA radioligand uptake.
Methodology: Unilateral cooling of the salivary glands was performed for 10 prostate cancer patients submitted to PET-
CT with Ga68PSMA, a compound used for diagnostic purposes and validated mainly in biochemical recurrence scenario. 
For cooling, icepacks were coupled to a device that attached them to one of the patient's parotid gland. Cooling started 30 
minutes before the injection of the radiopharmaceutical. The test was started 1h after the injection (acquisition t1), with 
an approximate duration of 30 minutes. A delayed image was made 4h after the injection (acquisition t4). The cooling was 
suspended just after the t1 acquisition. The packs were replaced every 30 minutes, and their temperature measured and 
recorded using infrared thermometers, for temperature standardization. Using OsiriX Dicom Viewer software, each of the 
glands (cooled parotid and control, cooled submandibular and control) was quantitatively assessed by the standardized 
maximum, mean and peak uptake values (SUVmax, SUVmean, and SUVpeak). The gland was delimited through an 
isocontour generated from a threshold of 10% of the SUVmax within a defined volume of interest (VOI). These four 
parameters were compared through the paired Student's T-test using R Commander software.
Results: There was no statistically significant reduction in any of the SUV parameters in the cooled glands compared 
to contralateral controls, both in t1 in t4. Regarding the submandibular glands, there were also found no alterations of 
statistical relevance, but the means of the three SUV parameters were higher in the cooled glands that in the controls.
Discussion: Results indicated no significant reduction of the radiation absorbed dose by cooled salivary glands. Despite 
the small sample size, that could reduce the ability to detect significant variations, results allow inferring that biological 
effects, if present, are probably small and of little clinical significance. Therefore, it was considered that results did not 
justify performing further exams since this is a high cost and complexity technique. The present findings corroborate with 
the other mentioned study.
Conclusion: The cooling of the salivary glands does not significantly reduce their uptake of radiopharmaceuticals, and no 
evidence supports this technique for sialotoxicity and xerostomia prevention in clinical practice.
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